(Q39515489)

12 September 2017

3-Deazaneplanocin A is a promising therapeutic agent for the eradication of tumor-initiating hepatocellular carcinoma cells (English)

1 reference

12 September 2017

hepatocellular carcinoma

1 reference

11

Atsushi Iwama

1 reference

12 September 2017

Tetsuhiro Chiba

1

1 reference

12 September 2017

Eiichiro Suzuki

2

1 reference

12 September 2017

Masamitsu Negishi

3

1 reference

12 September 2017

Atsunori Saraya

4

1 reference

12 September 2017

Satoru Miyagi

5

1 reference

12 September 2017

Takaaki Konuma

6

1 reference

12 September 2017

Satomi Tanaka

7

1 reference

12 September 2017

Motohisa Tada

8

1 reference

12 September 2017

Fumihiko Kanai

9

1 reference

12 September 2017

Fumio Imazeki

10

1 reference

12 September 2017

Osamu Yokosuka

12

1 reference

12 September 2017

language of work or name

English

0 references

publication date

20 August 2011

1 reference

International Journal of Cancer

12 September 2017

11

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

12 September 2017

130

1 reference

12 September 2017

2557-2567

1 reference

12 September 2017

11

1 reference

Stem cells, cancer, and cancer stem cells

12 September 2017

1 reference

Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell

21 January 2018

1 reference

Prospective identification of tumorigenic breast cancer cells

21 January 2018

1 reference

Cancer stem cells in solid tumours: accumulating evidence and unresolved questions

21 January 2018

1 reference

Side population purified from hepatocellular carcinoma cells harbors cancer stem cell-like properties

21 January 2018

1 reference

EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell features

21 January 2018

1 reference

Identification and characterization of tumorigenic liver cancer stem/progenitor cells

21 January 2018

1 reference

Significance of CD90+ cancer stem cells in human liver cancer

21 January 2018

1 reference

CD13 is a therapeutic target in human liver cancer stem cells

21 January 2018

1 reference

Tumour stem cells and drug resistance

21 January 2018

1 reference

Enhanced self-renewal capability in hepatic stem/progenitor cells drives cancer initiation.

21 January 2018

1 reference

Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells

21 January 2018

1 reference

Stem cell regulation by polycomb repressors: postponing commitment

21 January 2018

1 reference

The polycomb group gene product Ezh2 regulates proliferation and differentiation of murine hepatic stem/progenitor cells.

21 January 2018

1 reference

DZNep is a global histone methylation inhibitor that reactivates developmental genes not silenced by DNA methylation.

21 January 2018

1 reference

Pharmacologic disruption of Polycomb-repressive complex 2-mediated gene repression selectively induces apoptosis in cancer cells

21 January 2018

1 reference

Reversal of H3K9me2 by a small-molecule inhibitor for the G9a histone methyltransferase

21 January 2018

1 reference

Deregulation of H3K27 methylation in cancer

21 January 2018

1 reference

Genomic loss of microRNA-101 leads to overexpression of histone methyltransferase EZH2 in cancer

21 January 2018

1 reference

Distinct expression of polycomb group proteins EZH2 and BMI1 in hepatocellular carcinoma

21 January 2018

1 reference

The overexpression of polycomb group proteins Bmi1 and EZH2 is associated with the progression and aggressive biological behavior of hepatocellular carcinoma

21 January 2018

1 reference

MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer

21 January 2018

1 reference

Differentiation therapy of hepatocellular carcinoma in mice with recombinant adenovirus carrying hepatocyte nuclear factor-4alpha gene.

21 January 2018

1 reference

Cancer stem cells in hepatocellular carcinoma: Recent progress and perspective

21 January 2018

1 reference

Stem cell origin of cancer and differentiation therapy

21 January 2018

1 reference

EZH2 is essential for glioblastoma cancer stem cell maintenance

21 January 2018

1 reference

DNA methylation and gene silencing in cancer

21 January 2018

1 reference

Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancer

21 January 2018

1 reference

Gene silencing in cancer by histone H3 lysine 27 trimethylation independent of promoter DNA methylation

21 January 2018

1 reference

The role of EZH2 and DNA methylation in the silencing of the tumour suppressor RUNX3 in colorectal cancer

21 January 2018

1 reference

A Quantitative Assay for the Number of Murine Lymphoma Cells capable of Proliferation in vivo

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.26264

1 reference

12 September 2017

1 reference